Furthermore, SRX3305 blocks CLL cell migration toward CXCL-12 and CXCL-13, which are major chemokines involved in CLL cell homing and retention in microenvironment niches. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.